Liang, Y., Yi, S., Zhou, K., Jin, J., Yu, W., Ge, J., Zhu, Z., Liao, A., Peng, H., Zhou, F., Huang, X., Cui, G., Li, F., Jing, H., Shi, M., Tang, X., Wang, L., Li, Z., Huang, S., Zou, L., Li, Z., Mi, J., Yang, Y., Yang, W., Cao, J., Wang, W., Luo, C., Zhao, R., Qiu, L., Xu, W. (2025). Mesutoclax (ICP-248) monotherapy or combined with orelabrutinib demonstrates encouraging activity and safety in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Blood. https://doi.org/10.1182/blood-2025-5677